International Congress on Neuromuscular Diseases (ICNMD) 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Congress on Neuromuscular Diseases (ICNMD) 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
ICNMD 2026
Event type: Neurology, neuromuscular disorders, clinical research, medical devices, diagnostics, pharmaceuticals, rehabilitation, hospital care, scientific education
Estimated attendance: Expected to be a specialized international medical congress with a highly qualified audience of clinicians, researchers, healthcare providers, pharma teams, diagnostics companies, medical device brands, rehabilitation specialists, and academic delegates. Exact footfall depends on the host city and official registration volumes, but this type of congress typically attracts a focused B2B and scientific audience rather than a mass consumer crowd.
1️⃣ Who attends: Buyers / attendees
ICNMD 2026 is best understood as a high-value scientific and clinical gathering for the neuromuscular disease ecosystem. The audience is not broad consumer traffic; it is a specialized group of decision-makers, influencers, and technical professionals who care about diagnosis, treatment, clinical trials, patient management, and technology adoption in the neuromuscular space.
The most relevant attendee groups include:
- Neurologists and neuromuscular specialists
- Clinical researchers and principal investigators
- Academic faculty, professors, and medical school researchers
- Hospital department heads and medical directors
- Genetics specialists and diagnostic lab leaders
- Pharmaceutical medical affairs and clinical development teams
- Medical device and rehabilitation technology companies
- Physical medicine and rehabilitation professionals
- Patient advocacy organizations and nonprofit research groups
- Regulatory, publishing, and healthcare education professionals
From a buyer-list perspective, the strongest contacts are usually not just physicians, but also research leaders, hospital administrators, product managers, business development teams, clinical trial managers, education leads, and partnerships teams across healthcare and life sciences organizations.
2️⃣ Where the show is happening + attendee geographic origin
Location: Since the exact venue is not provided here, the final buyer strategy should be aligned to the confirmed host city and country for ICNMD 2026.
Attendee origin: This congress typically draws an international audience. Core attendees usually come from:
- North America
- Europe
- Middle East
- Asia-Pacific
- Latin America
Because the event is scientific and disease-focused, attendance is often global even when the physical event is hosted in one country. The audience is usually composed of delegates traveling from hospitals, universities, research centers, pharmaceutical companies, and specialist clinics worldwide.
Best geographic targeting:
- Global, with strong international reach
- Priority countries with advanced neurology, biotech, and clinical research ecosystems
- Local and regional healthcare institutions near the venue city
- International pharma and diagnostics companies with medical affairs teams
3️⃣ Audience reach
Reach type: Global
ICNMD 2026 has a distinctly global audience profile because neuromuscular disorders are a specialized clinical field with international research collaboration, cross-border trials, shared treatment guidelines, and multinational pharmaceutical interest. This makes the event attractive for companies that sell to hospitals, laboratories, academic institutions, and clinical research networks across multiple countries.
4️⃣ Sample buyer company names + websites
Below is a sample buyer list built for attendee-list targeting. These are strong organizations to prioritize because they are aligned with neuromuscular disease research, diagnostics, treatment, rehabilitation, or medical education. The list focuses on buyer-side accounts, not general visitors.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Roche | roche.com | Medical Affairs Director / Clinical Development Director / Product Manager | Strong fit for diagnostics, rare disease, clinical research, and neurology-focused medical engagement. |
| 2 | Novartis | novartis.com | Medical Science Liaison Manager / Disease Area Lead / Clinical Program Manager | Relevant for neurology, rare disease, and strategic scientific engagement. |
| 3 | Biogen | biogen.com | Therapeutic Area Lead / Medical Affairs Manager / Clinical Operations Lead | Highly relevant to neurology, rare disease, and specialty treatment ecosystems. |
| 4 | Sanofi | sanofi.com | Rare Disease Marketing Lead / Medical Affairs Director / Regional Brand Manager | Strong buyer fit for rare disease, specialty pharma, and patient-centric therapy programs. |
| 5 | Pfizer | pfizer.com | Medical Affairs Director / Global Product Manager / Clinical Research Manager | Large pharma with broad medical engagement and clinical research interests. |
| 6 | AbbVie | abbvie.com | Brand Director / Medical Science Liaison Director / Evidence Generation Lead | Strong fit for specialty therapeutics, scientific exchange, and healthcare partnerships. |
| 7 | UCB | ucb.com | Neurology Franchise Lead / Medical Affairs Manager / Field Medical Director | Excellent fit for neurological and rare disease communities. |
| 8 | Amicus Therapeutics | amicusrx.com | Rare Disease Marketing Director / Medical Affairs Lead | Focused rare disease company with direct relevance to neuromuscular and genetic conditions. |
| 9 | Dyne Therapeutics | dynetx.com | Clinical Development Director / Translational Research Lead | Relevant to genetic medicine and neuromuscular innovation. |
| 10 | GeneDx | genedx.com | Business Development Director / Medical Affairs / Genomics Partnerships Lead | Very strong fit for genetic testing, diagnostics, and rare disease identification. |
| 11 | QIAGEN | qiagen.com | Global Marketing Manager / Clinical Diagnostics Lead / Channel Partner Manager | Good fit for molecular diagnostics and lab workflows. |
| 12 | Thermo Fisher Scientific | thermofisher.com | Clinical Diagnostics Manager / Research Partnerships Manager | Relevant for lab tools, genomics, and clinical research solutions. |
| 13 | Illumina | illumina.com | Genomics Market Manager / Clinical Applications Manager | Strong fit for genetic testing, sequencing, and precision medicine audiences. |
| 14 | Medtronic | medtronic.com | Clinical Affairs Manager / Product Marketing Director / Therapy Development Lead | Relevant to medical devices, patient care technologies, and hospital adoption. |
| 15 | Stryker | stryker.com | Hospital Sales Director / Clinical Education Manager | Good fit for hospital systems, rehabilitation, and clinical education initiatives. |
| 16 | Boston Scientific | bostonscientific.com | Medical Affairs Manager / Regional Sales Director | Strong healthcare buyer profile for physician engagement and clinical solution discussions. |
| 17 | Reata Pharmaceuticals | biogen.com? (replace with current corporate domain if applicable) | Rare Disease Lead / Medical Strategy Director | Useful for specialized therapy targeting and scientific congress participation. |
| 18 | Muscular Dystrophy Association | mda.org | Research Partnerships Director / Development Director / Program Manager | Highly relevant nonprofit and advocacy buyer for clinical, research, and awareness partnerships. |
Top 5 best sample accounts to send first: Roche, Biogen, Novartis, GeneDx, and UCB. These five give you the best mix of pharma, diagnostics, rare disease, and neurology decision-makers.
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Medical Affairs Director
- Clinical Development Director
- Clinical Operations Manager
- Neurology Department Chair
- Neuromuscular Specialist
- Principal Investigator
- Research Program Director
- Genetics Lab Director
- Diagnostic Product Manager
- Rare Disease Marketing Director
- Patient Advocacy Lead
- Scientific Communications Manager
- Hospital Innovation Director
- Medical Education Manager
- Business Development Director, Healthcare
Industries to target:
- Hospital & Health Care
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Research
- Higher Education
- Health, Wellness & Fitness
- Information Services
- Biotech and diagnostics-related companies
- Professional Training & Coaching
Event type: Best described as an international medical congress and scientific conference with strong clinical, academic, and industry participation.
6️⃣ Estimated attendance / expected footfall
As a niche medical congress, the footfall is usually smaller than a general tradeshow but much stronger in quality. The real value is in audience precision rather than raw size.
Estimated attendance range: Moderate-to-high for a specialist congress, with a highly concentrated audience of clinical and scientific buyers.
The likely attendee mix includes:
- Physicians and neurologists
- Researchers and academics
- Pharma and diagnostics professionals
- Medical device companies
- Hospital and clinic decision-makers
- Patient advocacy and nonprofit leaders
For attendee-list sales, this type of event is best treated as a premium quality source rather than a high-volume list source.
7️⃣ Key focus areas & buyer engagement
The strongest subject areas at ICNMD 2026 are likely to center around:
- Neuromuscular disease diagnosis and treatment
- Genetics and molecular diagnostics
- Rare disease drug development
- Clinical trials and evidence generation
- Patient care pathways
- Rehabilitation and physical therapy approaches
- Biomarkers and advanced testing
- Medical education and scientific exchange
- Healthcare collaboration and research partnerships
- Innovation in specialty care and precision medicine
Buyer engagement angle: The best outreach message should frame the list as access to neurologists, researchers, hospital leaders, rare disease teams, diagnostics buyers, and clinical development professionals. That is much more valuable than a simple “conference attendee list” pitch.
8️⃣ Client-product fit note
To recommend the best buyers with precision, I need your client website before finalizing the list. The ideal buyer profile depends heavily on what your client sells.
Examples:
- If your client sells diagnostics, prioritize genetics labs, molecular testing companies, and clinical laboratory directors.
- If your client sells pharma services, target medical affairs, clinical development, and evidence generation teams.
- If your client sells medical devices, target hospital buyers, rehab leaders, and clinical procurement teams.
- If your client sells software or data solutions, target research institutions, clinical trial teams, and healthcare IT leaders.
- If your client sells education or publishing services, target academic institutions, medical associations, and training managers.
Once you share the client website, I can narrow this down into the exact best buyer accounts, job titles, and industry segments for your outreach.
9️⃣ Industry suggestions based on the industry list you provided
For this event, the best industry filters are:
- Hospital & Health Care
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Research
- Higher Education
- Health, Wellness & Fitness
- Information Services
- Professional Training & Coaching
- Management Consulting, if targeting healthcare strategy and advisory firms
Final recommendation
ICNMD 2026 is a strong event for targeted attendee-list sales if your client serves the healthcare, diagnostics, pharma, biotech, or medical education markets. It is not a mass-market business expo, but it is highly valuable because the audience is specialized and commercially relevant.
Best buyer segments to collect:
- Medical affairs teams
- Clinical development teams
- Neurology and rare disease leaders
- Genetic testing and diagnostic companies
- Hospital and academic research decision-makers
- Patient advocacy and nonprofit organizations
Quality rating for B2B attendee-list sales: 9/10
This is a high-value niche congress with excellent buyer quality, especially for healthcare, diagnostics, and life sciences outreach. The list becomes even more powerful once the exact client website and product category are known.
Next step: Please share your client website, and I will review it and give you the best buyers based on your client’s requirement.
Data sheet
| Event Name | International Congress on Neuromuscular Diseases (ICNMD) 2026 |
| Event Date | 7 July 2026 – 9 July 2026 |
| Event Status | Upcoming |
| Venue | Fortezza da Basso |
| City | Florence |
| State / Region | Tuscany |
| Country | Italy |
| Organizer | Organizer not publicly confirmed in the research input reviewed. |
| Official Event Website | Official current-edition event website not publicly verified in the research input reviewed. |
| Event Type | International scientific and clinical congress focused on neuromuscular diseases, neurology, clinical research, diagnostics, therapeutics, rehabilitation, and hospital care. |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | Global, with strong European clinical and academic participation likely. |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. Likely a specialized international medical congress with focused clinician, researcher, hospital, pharma, diagnostics, and rehabilitation attendance rather than mass consumer traffic. |
| Attendance Data Reliability | Estimated. No verified current-year attendance figure was available in the research input reviewed. |
| Main Purpose of Event | To convene neuromuscular disease specialists, researchers, healthcare institutions, therapeutic developers, diagnostics stakeholders, and rehabilitation professionals for scientific exchange, clinical education, partnership development, and technology adoption. |
The International Congress on Neuromuscular Diseases (ICNMD) 2026 is positioned as a specialized international medical and scientific congress serving the neuromuscular disease ecosystem. Based on the event title, timing, venue, and the supplied event description, the congress is expected to bring together neurologists, neuromuscular specialists, principal investigators, academic researchers, hospital leaders, diagnostic experts, rehabilitation professionals, and industry stakeholders involved in treatment, testing, device innovation, and clinical development.
From a commercial and lead-generation perspective, ICNMD 2026 matters because it concentrates high-value clinical and technical decision-makers in a narrow disease-area market. While it is not a broad consumer or high-footfall trade fair, it is likely to offer strong relevance for B2B outreach into hospital systems, clinical research networks, pharmaceutical medical affairs, rare-disease commercial teams, diagnostic laboratories, and rehabilitation technology providers. This makes it more suitable for precision account targeting than for mass attendee-list volume campaigns.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Neurologists and neuromuscular specialists | University hospitals, specialty clinics, neurology departments | Clinical evaluation, therapy adoption influence, protocol input | High relevance for therapeutics, diagnostics, clinical tools, and patient-management solutions |
| Clinical researchers and principal investigators | Academic medical centers, research institutes, trial sites | Clinical trial participation, evidence generation, study collaboration | Critical for CROs, sponsors, biomarker developers, and trial-enablement vendors |
| Hospital department heads and medical directors | Public hospitals, private hospitals, specialty centers | Budget input, care pathway decisions, procurement influence | Important for equipment, software, pathway optimization, and specialist service procurement |
| Genetics specialists and diagnostic laboratory leaders | Molecular labs, hospital labs, genetic testing centers | Selection of assays, workflows, lab platforms, and reference partnerships | High-value buyers for diagnostics, sample logistics, sequencing support, and data interpretation tools |
| Pharmaceutical medical affairs and clinical development teams | Biopharma companies, rare-disease divisions, specialty pharma groups | Scientific engagement, investigator relationships, pipeline positioning | Strong relevance for data providers, KOL engagement partners, and trial operations support |
| Medical device and rehabilitation technology teams | Assistive technology suppliers, device manufacturers, rehabilitation vendors | Product evaluation, partnership development, therapy support adoption | Relevant for mobility solutions, respiratory support, monitoring, and care technology |
| Rehabilitation specialists and allied health leaders | Rehab clinics, hospital rehab units, multidisciplinary care teams | Therapy pathway input, equipment recommendation, patient support planning | Strong fit for therapy devices, care programs, digital monitoring, and training services |
| Academic faculty and professors | Medical schools, universities, translational research groups | Scientific influence, publication impact, referral and network effects | Important for thought leadership, co-research, and product validation |
| Hospital procurement and administration teams | Hospital purchasing offices, administration units | Vendor onboarding, purchasing process, contract administration | Relevant for suppliers selling reimbursed equipment, diagnostics, and institutional services |
| Patient advocacy and disease-network leaders | Foundations, nonprofit disease organizations, care networks | Awareness, access, collaboration, patient engagement influence | Useful for outreach, education programs, and ecosystem partnerships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Florence | Host-city delegates, local hospitals, universities, and regional care providers | Medium | Local presence likely supports institutional attendance and operational convenience. |
| Tuscany | Regional clinicians, rehabilitation specialists, laboratory and academic delegates | Medium | Likely feeder region for nearby medical centers and university networks. |
| Major Italian healthcare hubs | Rome, Milan, Bologna, Naples, Turin, and other national clinical centers | High | National specialty attendance is likely for a disease-specific congress of this type. |
| Europe | Neurology departments, EU research groups, rare-disease networks, biopharma teams | High | The word “International” indicates cross-border participation is likely. |
| North America | Academic investigators, specialty pharma, rare-disease companies, trial collaborators | Medium | Likely among scientific speakers, sponsors, and senior clinical delegates if international participation is robust. |
| Global specialist markets | Selected delegates from Asia-Pacific, Middle East, and Latin America | Medium | Global reach is likely but should be validated from official registration or scientific program data when released. |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The event is positioned as an international congress in a specialist medical field. This strongly suggests cross-border participation from clinicians, academic researchers, and industry teams. |
| European / National | Secondary practical concentration | Italy and Europe are likely the strongest practical attendee pools due to venue location, medical travel patterns, and regional research collaboration. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer/company attendance list | Not publicly released | No verified current-year attendee, sponsor, exhibitor, speaker-organization, or buyer directory was available in the research input reviewed. | N/A | N/A | Confirmed Data Not Available |
| Recommended action | Verification step | Review the official congress website, scientific committee page, sponsor page, registration page, abstract portal, and final agenda once released to extract confirmed organizations. | N/A | Medical Director; Head of Neurology; Principal Investigator; Clinical Affairs Director; Hospital Procurement Manager | Confirmed Research Limitation |
| Usefulness for list building | Qualified but list-dependent | The event appears suitable for high-quality niche attendee profiling, but not for unsupported attendee-list claims. Official confirmation is required before naming organizations as participants. | N/A | N/A | Confirmed Research Limitation |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Head of Neurology | Clinical | Director / Department Head | Key clinical decision-maker for specialist adoption, referrals, and departmental priorities. |
| 2 | Neuromuscular Specialist | Clinical | Senior Individual Contributor / Consultant | Strong influence on diagnostics, therapy use, and KOL-driven adoption. |
| 3 | Principal Investigator | Research / Clinical Trials | Director / Lead | Core target for trial recruitment, site partnerships, and scientific credibility. |
| 4 | Medical Director | Medical Affairs / Hospital Leadership | Director / Executive | Influences care pathways, evaluations, and institutional relationships. |
| 5 | Director of Clinical Research | Research | Director | Useful for research partnerships, registries, data collection, and funding collaborations. |
| 6 | Laboratory Director | Diagnostics / Laboratory | Director | Decision-maker for testing capability, platforms, workflow, and external service contracts. |
| 7 | Director, Medical Affairs | Medical Affairs | Director | Relevant for scientific exchange, KOL engagement, and therapy education programs. |
| 8 | Clinical Development Director | R&D / Clinical Development | Director | Valuable for investigational therapies, trial design, and site selection discussions. |
| 9 | Rehabilitation Director | Rehabilitation / Operations | Director | Important for therapy protocols, assistive technology, and rehab service adoption. |
| 10 | Hospital Procurement Manager | Procurement | Manager | Relevant where the offering requires formal purchasing, contracts, or institutional onboarding. |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core industry for neurology departments, specialty clinics, and care providers. | Hospital adoption, departmental outreach, specialist pathway selling |
| 2 | Pharmaceuticals | Relevant for rare-disease therapeutics, specialty neurology portfolios, and trial programs. | Medical affairs, clinical development, scientific partnerships |
| 3 | Biotechnology | Emerging therapy developers and translational science companies are highly relevant. | Pipeline support, clinical collaboration, biomarker partnerships |
| 4 | Medical Devices | Relevant for monitoring devices, assistive technology, and specialist equipment. | Clinical device evaluation and rehab technology placement |
| 5 | Research | Academic and translational research groups are central to this congress profile. | Study collaboration, registry support, data collection tools |
| 6 | Higher Education | Medical schools and universities contribute faculty and investigators. | Academic engagement, co-publication, training partnerships |
| 7 | Information Technology & Services | Relevant for clinical data, digital health, workflow systems, and interoperability support. | Clinical software, analytics, digital patient monitoring |
| 8 | Computer Software | Applies to trial platforms, imaging analysis, and digital disease-management solutions. | Specialist software procurement and pilot programs |
| 9 | Health, Wellness & Fitness | Relevant for rehabilitation and long-term patient support ecosystems. | Rehab programs, patient-engagement tools, supportive care offerings |
| 10 | Nonprofit Organization Management | Patient foundations and disease networks often shape collaboration and awareness. | Education, advocacy, sponsorship, and awareness partnerships |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | No current-year public attendance figure verified in the research input. | Likely a focused specialist congress rather than a mass exhibition. |
| Exhibitor count | Not publicly confirmed | Unconfirmed | No verified exhibitor prospectus or exhibitor list reviewed. | Could include pharma, diagnostics, device, and rehabilitation suppliers if sponsorship/exhibition is offered. |
| Buyer count | Not publicly confirmed | Unconfirmed | No official buyer or delegate segmentation published in the research input. | “Buyer” behavior is likely embedded in clinical, hospital, lab, and pharma attendees rather than in a separate hosted-buyer format. |
| Speaker count | Not publicly confirmed | Unconfirmed | No verified agenda or faculty page reviewed. | Speaker organizations would be valuable later for account-based targeting. |
| Sponsor count | Not publicly confirmed | Unconfirmed | No verified sponsor page reviewed. | Sponsorship data should be captured once the organizer publishes support opportunities. |
| Historical attendance | Historical attendance data not verified in the research input. | Historical / prior-year evidence unavailable | No official prior-edition metrics reviewed. | Prior-year participation evidence. Not a confirmed attendee list for the current edition. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Neuromuscular diagnosis | Earlier and more accurate diagnosis pathways | Clinical evidence sharing, diagnostic workflow demonstrations | Genetic testing support, lab services, diagnostic software, biomarker tools |
| Clinical research and trials | Study collaboration, site capability, patient recruitment, data collection | PI meetings, research partnership outreach, site identification | CRO support, eClinical systems, patient registries, trial services |
| Rare-disease therapeutics | Scientific engagement and treatment education | Medical affairs networking, therapy positioning, KOL meetings | Specialty pharma solutions, evidence-generation support, educational programs |
| Rehabilitation and patient management | Mobility, respiratory support, therapy optimization, continuity of care | Demo-led engagement with rehab leaders and multidisciplinary teams | Assistive devices, rehab technology, remote monitoring, care coordination tools |
| Hospital care pathways | Standardization, referral optimization, budget justification | Institutional relationship building with clinical and procurement stakeholders | Workflow consulting, clinical software, specialty service models |
| Scientific education | Latest research, treatment updates, practice development | Faculty sponsorship, workshops, medical education collaboration | Education platforms, CME support, publication and communication services |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | Highly relevant for specialized healthcare, diagnostics, research, and rare-disease commercial offerings. |
| Decision-maker availability | High | Congress audience is likely to include department heads, investigators, medical directors, and scientific leaders. |
| Data collection potential | Medium | Strong only if the organizer publishes sponsor, agenda, faculty, partner, or attendee-related information. |
| Apollo targeting potential | High | The event maps well to Apollo filters across hospitals, pharma, biotech, research, labs, and medical devices. |
| Geographic targeting potential | High | Italy and Europe provide strong practical targeting zones, with global specialist extensions as needed. |
| Best outreach approach | High-touch ABM | Best suited for account-based targeting, scientific relevance messaging, and clinical-value-led outreach. |
| Overall lead quality | High | High-value niche audience, though list volume may be limited versus broader medical expos. |
| Best use case | Precision healthcare lead generation | Best for targeting rare-disease, neurology, diagnostics, hospital, and clinical research accounts. |
| Limitations / risks | Medium | Current-year public participant data was not verified in this review. Unsupported attendance claims should be avoided. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Biotechnology; Medical Devices; Research; Higher Education; Information Technology & Services; Computer Software; Health, Wellness & Fitness; Nonprofit Organization Management | Build disease-area account lists aligned with likely event participants and adjacent buyers. |
| Departments | Medical; Research; Clinical Affairs; Operations; Procurement; Information Technology; Business Development | Focus on departments involved in treatment adoption, trials, diagnostics, and institutional purchasing. |
| Seniority | Director; VP; Head; C-Level; Partner; Owner; Senior; Manager | Capture both strategic and implementation-level healthcare decision-makers. |
| Job titles | Head of Neurology; Neuromuscular Specialist; Medical Director; Principal Investigator; Director of Clinical Research; Laboratory Director; Director Medical Affairs; Clinical Development Director; Rehabilitation Director; Hospital Procurement Manager | Target the core clinical, research, and institutional buying audience. |
| Geography | Italy; Tuscany; Florence; broader Europe; selected global rare-disease and neurology hubs | Prioritize event-location markets first, then expand to international specialist accounts. |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Captures specialty firms, research institutes, and larger hospital or pharma systems. |
| Keywords | neuromuscular, neurology, muscular dystrophy, rare disease, clinical trials, rehabilitation, diagnostics, genetics, neurogenetics, motor neuron, myopathy, neuropathy | Improve relevance within broad healthcare datasets. |
| Technologies, if relevant | Clinical data platforms, genomics tools, remote monitoring, hospital software, lab informatics | Useful when selling digital, diagnostic, or workflow products. |
| Revenue range, if relevant | Mid-market to enterprise for pharma/biotech/device; institution-scale for hospital systems | Helps separate research-stage organizations from commercial-scale buyers. |
| Company type | Hospitals; Academic medical centers; Biopharma companies; Diagnostics labs; Medical device firms; Research institutes; Nonprofits | Refines outreach by buying model and clinical use case. |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| User-provided event brief | Input brief | Event name, city, region, country, venue, dates, and thematic scope supplied for this research task. | Moderate |
| Firenze Fiera / Fortezza da Basso | Official venue website | Venue operator reference for Fortezza da Basso in Florence. | High |
| Current-edition official event website / organizer page | Primary source not verified in this review | Organizer, official web domain, attendee counts, speaker list, sponsor list, and participant organizations remain to be verified from the official congress site when publicly available. | Pending verification |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Congress on Neuromuscular Diseases (ICNMD) 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.